WILKINS INVESTMENT COUNSEL INC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
WILKINS INVESTMENT COUNSEL INC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$13,339
-0.4%
130,950
-1.4%
3.61%
+3.1%
Q2 2023$13,396
+8.1%
132,750
-1.5%
3.50%
+7.5%
Q1 2023$12,393
+1.2%
134,710
-0.2%
3.26%
+1.1%
Q4 2022$12,244
-99.9%
134,960
+0.9%
3.22%
+8.2%
Q3 2022$10,169,000
-9.5%
133,785
+0.6%
2.98%
-0.2%
Q2 2022$11,238,000
-4.3%
132,947
-0.7%
2.98%
+12.6%
Q1 2022$11,748,000
+1.1%
133,880
+0.8%
2.65%
+3.3%
Q4 2021$11,615,000
+8.8%
132,790
+1.7%
2.56%
-1.8%
Q3 2021$10,680,000
-8.7%
130,590
+1.9%
2.61%
-9.2%
Q2 2021$11,696,000
+8.5%
128,190
+1.6%
2.88%
+3.0%
Q1 2021$10,780,000
-10.0%
126,115
-0.6%
2.79%
-15.8%
Q4 2020$11,977,000
+8.9%
126,835
+0.3%
3.32%
+1.1%
Q3 2020$10,998,000
+1.7%
126,470
+2.1%
3.28%
-4.2%
Q2 2020$10,817,000
+7.9%
123,845
+1.8%
3.42%
-6.4%
Q1 2020$10,028,000
-13.6%
121,620
-0.8%
3.66%
+11.1%
Q4 2019$11,604,000
+9.4%
122,545
+0.4%
3.30%
+3.4%
Q3 2019$10,604,000
-5.0%
122,020
-0.2%
3.19%
-4.9%
Q2 2019$11,167,000
-5.2%
122,295
-0.1%
3.35%
-5.8%
Q1 2019$11,774,000
+11.0%
122,470
-0.9%
3.56%
+1.2%
Q4 2018$10,604,000
-0.4%
123,570
-0.0%
3.51%
+10.2%
Q3 2018$10,651,000
+13.9%
123,620
-0.1%
3.19%
+8.3%
Q2 2018$9,350,000
-2.2%
123,770
+4.7%
2.94%
-2.6%
Q1 2018$9,558,000
-2.0%
118,220
+1.7%
3.02%
+3.8%
Q4 2017$9,757,000
-3.4%
116,210
-1.3%
2.91%
-5.3%
Q3 2017$10,104,000
+2.9%
117,690
+0.1%
3.07%
-1.5%
Q2 2017$9,815,000
+12.9%
117,590
+0.4%
3.12%
+12.0%
Q1 2017$8,696,000
+11.3%
117,090
+9.2%
2.79%
+11.9%
Q4 2016$7,811,000
+4.9%
107,240
+13.7%
2.49%
-0.4%
Q3 2016$7,449,000
-4.1%
94,340
+0.2%
2.50%
-4.9%
Q2 2016$7,768,000
+18.6%
94,150
+4.1%
2.63%
+9.5%
Q1 2016$6,549,000
+1.2%
90,400
+20.2%
2.40%
-1.2%
Q4 2015$6,469,000
-7.2%
75,184
-0.8%
2.43%
-8.9%
Q3 2015$6,968,000
-6.7%
75,809
-0.2%
2.67%
-2.0%
Q2 2015$7,466,000
-1.9%
75,925
-1.6%
2.72%
+1.2%
Q1 2015$7,608,000
+5.9%
77,150
-0.5%
2.69%
+7.8%
Q4 2014$7,181,000
-2.2%
77,500
-0.6%
2.50%
-4.8%
Q3 2014$7,342,000
+3.2%
78,000
-0.7%
2.62%
+4.5%
Q2 2014$7,111,000
+6.8%
78,550
+0.3%
2.51%
+2.0%
Q1 2014$6,661,000
+5.2%
78,350
-0.5%
2.46%
-6.5%
Q4 2013$6,330,000
+4.9%
78,750
+0.1%
2.63%
-4.5%
Q3 2013$6,035,000
+6.5%
78,675
-1.9%
2.75%
+4.7%
Q2 2013$5,669,00080,1752.63%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
MANAGED ASSET PORTFOLIOS, LLC 237,047$19,165,0006.16%
PRENTISS SMITH & CO INC 127,005$10,268,0005.38%
EXENCIAL WEALTH ADVISORS, LLC 195,903$15,839,0004.71%
Osher Van de Voorde Investment Management 106,315$8,596,0004.37%
BROWN BROTHERS HARRIMAN & CO 8,924,544$721,549,0004.16%
CGOV Asset Management 874,998$70,744,0004.08%
PROFESSIONAL ADVISORY SERVICES INC 218,844$17,694,0003.83%
COMPASS CAPITAL MANAGEMENT, INC 304,931$24,654,0003.69%
First Fiduciary Investment Counsel, Inc. 226,636$18,324,0003.64%
SUMMITRY LLC 456,575$36,914,0003.41%
View complete list of NOVARTIS A G shareholders